Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart drug repurposed to fight arthritis pain?

NCT ID NCT07516769

First seen Apr 26, 2026 · Last updated May 23, 2026 · Updated 5 times

Summary

This study tests if nicorandil, a heart medication, can reduce inflammation and improve symptoms in people with active rheumatoid arthritis. About 46 adults who are already on standard arthritis drugs will take nicorandil for 3 months. Researchers will measure joint swelling, pain, and quality of life to see if the drug helps control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHUMATOID ARTHISIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tanta university

    RECRUITING

    Tanta, Gharbia Governorate, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.